Transglutaminase 3 IgA

A chronic, intensely itchy rash with tiny blisters on the elbows, knees, buttocks, or scalp can have a surprising root cause: gluten. This antibody offers a useful blood signal that such a rash is being driven by a gluten-related immune reaction rather than eczema or another common skin problem.

The rash, called dermatitis herpetiformis, is the skin form of celiac disease. Knowing whether this antibody is elevated can point you toward the right diagnosis and the one treatment that actually resolves it, which is removing gluten.

What This Antibody Targets

TG3 IgA (immunoglobulin A antibodies against transglutaminase 3) is an antibody your immune system makes against transglutaminase 3, an enzyme found mainly in the skin that helps hold the outer skin barrier together. The test measures that antibody in your blood, not the enzyme itself, and its presence reflects a gluten-driven autoimmune process rather than any defect in the enzyme.

These antibodies are produced by immune cells in the lining of your small intestine, not in the skin. Dietary gluten sets off the reaction, which is why this is fundamentally a gut-linked condition that happens to show up on your skin.

Dermatitis Herpetiformis

This is the disease most tightly linked to elevated TG3 IgA. In one small study of people with untreated dermatitis herpetiformis eating a normal diet, these antibodies were found in 36 of 38 (95%), compared with 30 of 38 (79%) for the standard celiac antibody in the same group. Larger and more recent research has tempered that early finding: a 2023 international study of 242 patients found this antibody was actually slightly less sensitive (72.7%) than the standard celiac antibody (78.5%), and a 2025 meta-analysis put its pooled sensitivity lower still. So this antibody is a useful supporting marker for the skin condition, but it is not reliably more sensitive than standard celiac serology.

Its usefulness extends to people already on treatment. Among a small group with long-standing dermatitis herpetiformis who still needed the drug dapsone to control symptoms, all seven remained positive for this antibody, while only three of the seven still had the standard celiac antibody. That group was very small, so the finding is suggestive rather than definitive. A skin biopsy that stains for antibody deposits remains the most definitive test, but this blood marker is a strong supporting clue.

The Celiac Disease Connection

Elevated TG3 IgA is not limited to the skin condition. Adults with celiac disease can also have raised levels, though they tend to run higher in untreated dermatitis herpetiformis than in celiac disease without a rash. This overlap exists because both conditions share the same trigger, gluten, and the same underlying gut autoimmunity.

The overlap also limits how specific this marker is. In celiac patients without any rash, antibody deposits can still appear in the skin, and their presence correlated with higher blood levels of this antibody. So a positive result signals gluten-related autoimmunity, but it does not by itself confirm the skin disease.

Why One Reading Is Not Enough

A single measurement is a snapshot. The real value of this antibody comes from tracking it over time, especially once you change your diet. Levels are highly responsive to gluten removal and tend to fall and often disappear on a strict gluten-free diet, so serial testing shows whether your treatment is working. This is a specialized marker without a single universal cutoff, which is another reason a trend tells you more than one number.

If you are starting or tightening a gluten-free diet, get a baseline first, then retest in 3 to 6 months, and at least once a year after that. These are practical intervals rather than a formal guideline protocol. A downward trend is reassuring evidence that the underlying reaction is quieting. A stubborn or rising level suggests ongoing gluten exposure, sometimes from hidden sources.

When Results Can Be Misleading

• Already off gluten: if you cut gluten before testing, levels may have already dropped, producing a falsely reassuring result even when disease is present.
• Low total IgA: because this is an IgA-based test, people with selective IgA deficiency can test falsely negative, so a total IgA level should be checked alongside it.
• Assay differences: different labs use different methods and thresholds, so a value from one lab may not match another. Compare results run by the same lab where possible.
• Persistent tissue disease: related celiac blood tests can miss ongoing intestinal damage on a gluten-free diet, so a normal result does not guarantee full recovery.

What to Do With an Unexpected Result

A positive or rising result is a reason to act, not to panic. Pair this antibody with a total IgA level and the standard celiac antibody, tissue transglutaminase IgA (the TG2 marker), to build a fuller picture. If a gluten-related condition is likely, the next steps usually involve a dermatologist for a skin biopsy and a gastroenterologist for intestinal evaluation before you commit to a lifelong diet change.

Do not start a gluten-free diet before testing is complete. Removing gluten lowers these antibodies and can heal the tissue changes that confirm the diagnosis, which makes a clear answer much harder to reach. If your standard celiac panel looked normal but you have an unexplained itchy, blistering rash, this antibody is exactly the kind of marker that can catch what the routine panel missed.